Weekly Dose of AI Adoption

Weekly Dose of AI Adoption

From Weekly Dose of GenAI Adoption by Indy Sawhney

May 9, 2026 · 6 min · Season 1 · Episode 109

About this episode

Indy Sawhney discusses a strategic framework for calculating the ROI of agentic AI in the pharmaceutical industry.

This newsletter from Indy Sawhney provides a strategic framework for calculating the Return on Investment (ROI) of agentic AI within the pharmaceutical industry. It emphasizes that traditional financial models often fail because they ignore the high program costs of regulated deployments and rely too heavily on minor labor savings. Instead, the text argues that the primary financial value of AI stems from timeline compression, which allows drugs to reach the market faster. To secure funding, leaders are encouraged to collaborate with CFOs and technical stakeholders to validate these assumptions with real production data. Ultimately, the source serves as a practical playbook for navigating the complex financial and regulatory realities of large-scale AI adoption.

More episodes of Weekly Dose of GenAI Adoption

Explore listener stats, chart rankings, contacts and more on the Weekly Dose of GenAI Adoption podcast page.